Watchman Implantation without Warfarin Transition is Feasible in Patients with Atrial Fibrillation

Summary

The first formal analysis of the ASA-Plavix (ASAP) Registry found that the Watchman left atrial appendage closure device can be used safely and effectively in patients with atrial fibrillation for whom anticoagulants are contraindicated.

  • Cardiology Clinical Trials
  • Interventional Techniques & Devices
  • Arrhythmias
View Full Text